Raymond James Financial Services Advisors, Inc. Celldex Therapeutics, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$28.95 - $55.99 $439,461 - $849,928	-15,180 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$20.71 - $35.37 $1,470 - $2,511	-71 Reduced 0.47%	15,180 $508,000
Q1 2021 May 14, 2021	BUY	$16.19 - $29.91 $1,149 - $2,123	71 Added 0.47%	15,251 $314,000
Q4 2020 Feb 12, 2021	SELL	$14.99 - $22.75 $299 - $455	-20 Reduced 0.13%	15,180 $266,000
Q3 2020 Nov 04, 2020	SELL	$9.65 - $15.19 $1,930 - $3,038	-200 Reduced 1.3%	15,200 $225,000
Q2 2020 Jul 17, 2020	SELL	$1.61 - $13.41 $2,553 - $21,268	-1,586 Reduced 9.34%	15,400 $200,000
Q1 2020 Apr 21, 2020	BUY	$1.55 - $3.07 $71 - $141	46 Added 0.27%	16,986 $28,000
Q2 2019 Aug 06, 2019	BUY	$2.43 - $5.09 $41,164 - $86,224	16,940 New	16,940 $45,000

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

Wellington Management Group LLP Boston, MA

9.24M
Shares

$250 Million
0.06% of portfolio
Black Rock Inc. New York, NY

4.69M
Shares

$127 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.87M
Shares

$105 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

3.46M
Shares

$93.5 Million
9.64% of portfolio
Eventide Asset Management, LLC Boston, MA

3.33M
Shares

$90 Million
1.99% of portfolio

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account